Gastroesophageal reflux disease and non-digestive tract diseases

References

• Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20
   PubMed Web of Science ®Google Scholar
• Kunz JS, Hemann B, Edwin Atwood J, et al. Is there a link between gastroesophageal reflux disease and atrial fibrillation? Clin Cardiol 2009;32:584-7
   PubMed Web of Science ®Google Scholar
• Shimazu H, Nakaji G, Fukata M, et al. Relationship between atrial fibrillation and gastroesophageal reflux disease: a Multicenter Questionnaire Survey. Cardiology 2011;119:217-23
   PubMed Web of Science ®Google Scholar
• Huang CC, Chan WL, Luo JC, et al. Gastroesophageal reflux disease and atrial fibrillation: a nationwide population-based study. PLoS One 2012;7:1-5
   Web of Science ®Google Scholar
• Wang H, Yan HM, Tang MX, et al. Increased serum levels of microvesicles in nonvalvular atrial fibrillation determined by ELISA using a specific monoclonal antibody AD-1. Clin Chim Acta 2010;411:1700-4
   PubMed Web of Science ®Google Scholar
• Bruins P, te Velthuis H, Yazdanbakhsh AP, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997;96:35428
   Web of Science ®Google Scholar
• Pepys MB, Hirschfield GM, Tennent GA, et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006;440:1217-21
   PubMed Web of Science ®Google Scholar
• Boos CJ, Anderson RA, Lip GYH. Is atrial fibrillation an inflammatory disorder? European Heart Journal 2006;27:136-49
   PubMed Web of Science ®Google Scholar
• Li J, Solus J, Chen Q, et al. Role of inflammation and oxidative stress in atrial fibrillation. Heart Rhythm 2010;7:438-44
   PubMed Web of Science ®Google Scholar
• Gerson LB, Friday K, Triadafilopoulos G. Potential relationship between gastroesophageal reflux disease and atrial arrhythmias. J Clin Gastroenterol 2006;40:828-32
   PubMed Web of Science ®Google Scholar
• Aizawa T. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J 2010;74:262-70
   PubMed Web of Science ®Google Scholar
• Isomoto H, Saenko VA, Kanazawa Y, et al. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol 2004;99:589-97
   PubMed Web of Science ®Google Scholar
• Ma J, Altomare A, de la Monte S, et al. HCl-induced inflammatory mediators in esophageal mucosa increase migration and production of H2O2 by peripheral blood leukocytes. Am J Physiol Gastrointest Liver Physiol 2010;299:G791-8
   PubMed Web of Science ®Google Scholar
• Rieder F, Cheng L, Harnett KM, et al. Gastroesophageal reflux disease-associated esophagitis induces endogenous cytokine production leading to motor abnormalities. Gastroenterology 2007;132:154-65
   PubMed Web of Science ®Google Scholar
• Weigl M, Gschwantler M, Gatterer E, et al. Reflux esophagitis in the pathogenesis of paroxysmal atrial fibrillation: results of a pilot study. South Med J 2003;96:1128-32
   PubMed Web of Science ®Google Scholar
• Gerson LB, Friday K, Triadafilopoulos G. Potential relationship between gastroesophageal reflux disease and atrial arrhthmias. J Clin Gastroenterol 2006;40:828-32
   PubMed Web of Science ®Google Scholar
• Pastoris O, Verri M, Boschi F, et al. Effects of esomeprazole on glutathione levels and mitochondrial oxidative phosphorylation in the gastric mucosa of rats treated with indomethacin. Naunyn Schmiedebergs Arch Pharmacol 2008;378:421-9
   PubMed Web of Science ®Google Scholar
• Martinek M, Hassanein S, Bencsik G, et al. Acute development of gastroesophageal reflux after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm 2009;6:1457-62
   PubMed Web of Science ®Google Scholar
• Casanova C, Baudet JS, del Valle Velasco M, et al. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J 2004;23:841-5
   PubMed Web of Science ®Google Scholar
• Martinek M, Bencsik G, Aichinger J, et al. Esophageal damage during radiofrequency ablation of atrial fibrillation: impact of energy settings, lesion sets, and esophageal visualization. J Cardiovasc Electrophysiol 2009;20:726-33
   PubMed Web of Science ®Google Scholar
• Cummings JE, Schweikert RA, Saliba WI, et al. Assessment of temperature, proximity, and course of the esophagus during radiofrequency ablation within the left atrium. Circulation 2005;112:459-64
   PubMed Web of Science ®Google Scholar
• Sakae TM, Pizzichini MM, Teixeira PJ, et al. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis. J Bras Pneumol 2013;39:259-71
   PubMed Web of Science ®Google Scholar
• Kim J, Lee JH, Kim Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study. BMC Pulm Med 2013;13:51
   PubMed Web of Science ®Google Scholar
• Sasaki T, Nakayama K, Yasuda H, et al. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc 2009;57:1453-7
   PubMed Web of Science ®Google Scholar
• Rogha M, Behravesh B, Pourmoghaddas Z. Association of gastroesophageal reflux disease symptoms with exacerbations of chronic obstructive pulmonary disease. J Gastrointestin Liver Dis 2010;19:253-6
   PubMed Web of Science ®Google Scholar
• Lee AL, Button BM, Denehy L, et al. Proximal and distal gastro-oesophageal reflux in chronic obstructive pulmonary disease and bronchiectasis. Respirology 2014;19:211-17
   PubMed Web of Science ®Google Scholar
• Mokhlesi B. Clinical implications of gastroesophageal reflux disease and swallowing dysfunction in COPD. Am J Respir Med 2003;2:117-21
   PubMedGoogle Scholar
• Barnes PJ. Neurogenic inflammation in the airways. Respir Physiol 2001;125:145-54
   PubMedGoogle Scholar
• Patti MG, Tedesco P, Golden J, et al. Idiopathic pulmonary fibrosis: how often is it really idiopathic? J Gastrointest Surg 2005;9:1053-6
   PubMed Web of Science ®Google Scholar
• Han MK. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;28:884-5
   PubMed Web of Science ®Google Scholar
• Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824
   PubMed Web of Science ®Google Scholar
• Lee JS, Collard HR, Anstrom KJ, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med 2013;1:369-76
   PubMed Web of Science ®Google Scholar
• Lee JS, Ryu JH, Elicker BM, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011;184:1390-4
   PubMed Web of Science ®Google Scholar
• Davis CS, Mendez BM, Flint DV, et al. Pepsin concentrations are elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis after lung transplantation. J Surg Res 2013;185:e101-8
   Web of Science ®Google Scholar
• Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006;354:2340-8
   PubMed Web of Science ®Google Scholar
• Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and metaanalysis. Am J Gastroenterol 2006;101:2619-28
   PubMed Web of Science ®Google Scholar
• Hampel H, Abraham NS, El-Serag HB. Metaanalysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143:199-211
   PubMed Web of Science ®Google Scholar
• Minenna MF, Palieri A, Nacchiero MC, et al. Macronutrient dietary intake and gastroesophageal reflux disease: a clinic and pH-metric study. Digest Liver Dis 2007;39:AS1
   Google Scholar
• Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg 2005;15:1225-32
   PubMed Web of Science ®Google Scholar
• Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of astroesophageal reflux disease. Am J Gastroenterol 2013;108:308-28
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Hashmi A, Garcia J, et al. Visceral abdominal obesity measured by CT scan is associated with an increased risk of Barrett’s oesophagus: a case-control study. Gut 2014;63:220-9
   PubMed Web of Science ®Google Scholar
• Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg 2005;15:1225-32
   PubMed Web of Science ®Google Scholar
• Merrouche M, Sabaté JM, Jouet P, et al. Gastro-esophageal reflux and esophageal motility disorders in morbidly obese patients before and after bariatric surgery. Obes Surg 2007;17:894-900
   PubMed Web of Science ®Google Scholar
• Iovino P, Angrisani L, Galloro G, et al. Proximal stomach function in obesity with normal or abnormal oesophageal acid exposure. Neurogastroenterol Motil 2006;18:425-32
   PubMed Web of Science ®Google Scholar
• Koppman JS, Poggi L, Szomstein S, et al. Esophageal motility disorders in the morbidly obese population. Surg Endosc 2007;21:761-4
   PubMed Web of Science ®Google Scholar
• Ryan AM, Healy LA, Power DG, et al. Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state. Ann Surg 2008;247:909-15
   PubMedGoogle Scholar
• Jansson C, Nordenstedt H, Wallander MA, et al. Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based study. Aliment Pharmacol Ther 2008;27:58-65
   PubMed Web of Science ®Google Scholar
• Ruigómez A, García Rodríguez LA, Wallander MA, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004;20:751-60
   PubMed Web of Science ®Google Scholar
• Lluch I, Ascaso JF, Mora F, et al. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999;94:919-24
   PubMed Web of Science ®Google Scholar
• Hsu CS, Wang PC, Chen JH, et al. Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011;34:994-1004
   PubMed Web of Science ®Google Scholar
• Iyer PG, Borah BJ, Heien HC, et al. Association of Barrett’s esophagus with type II Diabetes Mellitus: results from a large population-based case-control study. Clin Gastroenterol Hepatol 2013;11:1108-14
   PubMed Web of Science ®Google Scholar
• Greer KB, Thompson CL, Brenner L, et al. Association of insulin and insulin-like growth factors with Barrett’s oesophagus. Gut 2012;61:665-72
   PubMed Web of Science ®Google Scholar
• Rubenstein JH, Morgenstern H, McConell D, et al. Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett’s esophagus. Gastroenterology 2013;145:1237-44
   PubMed Web of Science ®Google Scholar
• Murray IA, Perdew GH. Omeprazole stimulates the induction of human insulin-like growth factor binding protein-1 through aryl hydrocarbon receptor activation. J Pharmacol Exp Ther 2008;324:1102-10
   PubMed Web of Science ®Google Scholar